Zentalis Pharmaceuticals, Inc. (ZNTL) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -32.96M | -30.94M | -26.96M | -34.71M | -32.64M | -39.7M | -44.05M | -35.14M | -51.97M | -40.6M | -38.66M | -79.28M | -49.28M | -37.33M | -33.2M | -43.03M | -50.2M | -37.02M | -33.49M | -46.11M |
| Operating CF Margin % | - | - | - | - | - | -147.78% | - | - | -128.14% | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -0.98% | 22.07% | 38.78% | 1.23% | 37.21% | 2.21% | -13.91% | 55.67% | -5.46% | -8.76% | -16.46% | -84.24% | 1.82% | -0.83% | 0.87% | 6.69% | -33.97% | -35.33% | -62.86% | -109.29% |
| Net Income | -35.35M | -35.22M | -26.69M | -26.87M | -48.28M | -47.47M | -40.16M | -88.28M | 10.07M | -60.92M | -55.54M | -112.56M | -63.26M | -54.98M | -54.5M | -68.39M | -59.24M | -50.06M | -10.49M | -55.06M |
| Depreciation & Amortization | 151K | 157K | 160K | 160K | 262K | 317K | 321K | 327K | 324K | 337K | 348K | 344K | 360K | 359K | 375K | 348K | 344K | 209K | 137K | 119K |
| Stock-Based Compensation | 0 | 3.12M | 4.83M | 6.29M | 6.49M | 31.36M | 10.36M | 12.71M | 12.83M | 0 | 13.87M | 13.34M | 13.73M | 9.61M | 10.32M | 16.76M | 10.15M | 0 | 7.66M | 9.92M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -756K | -97K | -769K | -125K | 74K | -74K | -15K | 0 | 0 |
| Other Non-Cash Items | 2.97M | 2.38M | -4.09M | -5.95M | 7.14M | -16.83M | -7.31M | 26M | -58.89M | 9.71M | -2.12M | 25.52M | 4M | 4.47M | 1.1M | 5.19M | 1.9M | 10.48M | -43.4M | 232K |
| Working Capital Changes | -728K | -1.38M | -1.17M | -8.33M | 1.75M | -7.08M | -7.26M | 14.1M | -16.3M | 10.27M | 4.78M | -5.16M | -4.02M | 3.98M | 9.63M | 2.99M | -3.27M | 2.37M | 12.61M | -1.32M |
| Change in Receivables | 0 | 0 | 0 | 0 | 5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4K | 4K | 0 | 0 | 104K | -103K | 243K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.45M | -733K | 0 | -10.58M | -4.02M | 0 | -12.01M | 11.8M | -15.25M | 10.4M | 6.33M | -4.39M | 0 | 16.1M | 6.45M | 4.6M | -574K | 1.61M | 7.47M | 1.53M |
| Cash from Investing | 30.01M | 32.45M | 28.32M | 30.38M | 40.48M | 32.28M | 48.24M | 34.49M | 61.55M | -42.06M | -117.45M | 72.93M | 42.12M | -11.89M | 20.02M | -142.1M | 19.8M | 43.27M | -141.44M | 66.6M |
| Capital Expenditures | -34K | 0 | 0 | 0 | 0 | 0 | 0 | -181K | -40K | -173K | -91K | -319K | 0 | -160K | -1.66M | -278K | -450K | -2.19M | -2.66M | -819K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | 0.1% | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 569K | 0 | 564K | 5K | 0 | 0 | 65K | 0 | 0 | 117.36K | -73.25K | 0 | 11.73K | -21.68K | 141.82K | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -440K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -117.36K | 73.25K | 0 | -11.73K | 21.68K | -141.82K | 0 | 0 | -14.32M | 0 |
| Cash from Financing | -1.12M | -4.59M | 115K | 0 | 189K | 0 | 92K | 9K | 7K | 0 | 309K | 236.62M | 373K | 49.74M | 589K | 209.46M | 1.26M | 12.27M | 166.57M | -316K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 331K | -4.59M | 115K | 0 | 189K | 0 | 92K | 9K | 248K | 0 | 309K | 236.62M | 373K | 49.74M | 589K | 209.46M | 1.26M | 13.41M | 166.18M | 70K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -1.45M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -241K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.15M | 386K | -386K |
| Net Change in Cash | -4.07M | -3.08M | 1.47M | -4.33M | 8.03M | -7.42M | 4.34M | -640K | 9.58M | -82.71M | -155.81M | 230.28M | -6.79M | 518K | -12.59M | 24.33M | -29.14M | 18.91M | -8.36M | 20.17M |
| Free Cash Flow | -32.99M | -30.94M | -26.96M | -34.71M | -32.64M | -39.7M | -44.05M | -35.32M | -52.01M | -40.77M | -38.76M | -79.59M | -49.28M | -37.49M | -34.86M | -43.3M | -50.65M | -39.21M | -36.15M | -46.93M |
| FCF Margin % | - | - | - | - | - | -147.78% | - | - | -128.24% | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -1.08% | 22.07% | 38.78% | 1.73% | 37.26% | 2.62% | -13.65% | 55.62% | -5.54% | -8.76% | -11.18% | -83.8% | 2.69% | 4.39% | 3.57% | 7.73% | -33.61% | -39.95% | -75.45% | -112.77% |
| FCF per Share | -0.47 | -0.43 | -0.37 | -0.48 | -0.46 | -0.56 | -0.62 | -0.50 | -0.73 | -0.58 | -0.55 | -1.31 | -0.83 | -0.63 | -0.61 | -0.85 | -1.12 | -0.87 | -0.81 | -1.15 |
| FCF Conversion (FCF/Net Income) | 0.93x | 0.88x | 1.01x | 1.29x | 0.68x | 0.84x | 1.10x | 0.40x | -5.16x | 0.67x | 0.70x | 0.70x | 0.78x | 0.68x | 0.61x | 0.63x | 0.85x | 0.74x | 7.99x | 0.84x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |